Skip to main content
Erschienen in: PharmacoEconomics 6/2007

01.06.2007 | Review Article

A Systematic Review of Economic Evaluation Literature in Thailand

Are the Data Good Enough to be Used by Policy-Makers?

verfasst von: Dr Yot Teerawattananon, Steve Russell, Miranda Mugford

Erschienen in: PharmacoEconomics | Ausgabe 6/2007

Einloggen, um Zugang zu erhalten

Abstract

In many countries, including Thailand, there is an increasing impetus to use economic evaluation to allow more explicit and transparent healthcare priority setting. However, an important question for policy makers in low- and middle-income countries is whether it is appropriate and feasible to introduce economic evaluation data into healthcare priority-setting decisions. In addition to ethical, social and political issues, information supply challenges need to be addressed. This paper systematically reviewed the literature on economic evaluation of health technology in Thailand published between 1982 and 2005. Its aim was to analyse the quantity, quality and targeting of economic evaluation studies that can provide a framework for those conducting similar reviews in other settings.
The review revealed that, although the number of publications reporting economic evaluations has increased significantly in recent years, serious attention needs to be given to the quality of reporting and analysis. Furthermore, there is an absence of economic evaluation publications for 15 of the top 20 major health problems in Thailand, indicating a poor distribution of research resources towards the determination of cost-effective interventions for diminishing the disease burden of certain major health problems. If economic evaluation is only useful for policy makers when performed correctly and reported accurately, these findings depict information barriers to using economic evaluation to assist health decision-making processes in Thailand.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Doherty J, Kamae I, Lee KKC, et al. What is next for pharmacoeconomics and outcomes research in Asia? Value Health 2004; 7 (2): 118–132PubMedCrossRef Doherty J, Kamae I, Lee KKC, et al. What is next for pharmacoeconomics and outcomes research in Asia? Value Health 2004; 7 (2): 118–132PubMedCrossRef
2.
Zurück zum Zitat Tangcharoesnathien V, Srithamrongswat S, Pittayarangsarit S. Overview of health insurance systems. In: Thammathataree J, editor. Health insurance systems in Thailand. Bangkok: Desire Publisher; 2001: 28–37 Tangcharoesnathien V, Srithamrongswat S, Pittayarangsarit S. Overview of health insurance systems. In: Thammathataree J, editor. Health insurance systems in Thailand. Bangkok: Desire Publisher; 2001: 28–37
3.
Zurück zum Zitat Teerawattananon Y, Tangcharoensathien V. Designing a reproductive health services package in the universal health insurance scheme in Thailand: match and mismatch of need, demand and supply. Health Policy Plan 2004; 19 Suppl. 1: i31–i39PubMedCrossRef Teerawattananon Y, Tangcharoensathien V. Designing a reproductive health services package in the universal health insurance scheme in Thailand: match and mismatch of need, demand and supply. Health Policy Plan 2004; 19 Suppl. 1: i31–i39PubMedCrossRef
4.
Zurück zum Zitat Pannarunothai S, Patmasiriwat D, Srithamrongsawat S. Universal health coverage in Thailand: ideas for reform and policy struggling. Health Policy 2004; 68 (1): 17–30PubMedCrossRef Pannarunothai S, Patmasiriwat D, Srithamrongsawat S. Universal health coverage in Thailand: ideas for reform and policy struggling. Health Policy 2004; 68 (1): 17–30PubMedCrossRef
5.
Zurück zum Zitat Hoffmann C. The influence of economic evaluation studies on decision making: a european survey. Health Policy 2000; 52 (3): 179–192PubMedCrossRef Hoffmann C. The influence of economic evaluation studies on decision making: a european survey. Health Policy 2000; 52 (3): 179–192PubMedCrossRef
6.
Zurück zum Zitat Teerawattananon Y, Mugford M, Tangcharoensathien V. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand. Value Health 2007; 10 (1): 61–72PubMedCrossRef Teerawattananon Y, Mugford M, Tangcharoensathien V. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand. Value Health 2007; 10 (1): 61–72PubMedCrossRef
7.
Zurück zum Zitat Stolk EA, Brouwer WB, Busschbach JJ. Rationalising rationing: economic and other considerations in the debate about funding of Viagra. Health Policy 2002; 59 (1): 53–63PubMedCrossRef Stolk EA, Brouwer WB, Busschbach JJ. Rationalising rationing: economic and other considerations in the debate about funding of Viagra. Health Policy 2002; 59 (1): 53–63PubMedCrossRef
8.
Zurück zum Zitat Walker D, Fox-Rushby J. Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature. Health Econ 2000; 9: 681–698PubMedCrossRef Walker D, Fox-Rushby J. Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature. Health Econ 2000; 9: 681–698PubMedCrossRef
9.
Zurück zum Zitat Lee KS, Brouwer WB, Lee SI, et al. Introducing economic evaluation as a policy tool in Korea: will decision makers get quality information? A critical review of published Korean economic evaluations. Pharmacoeconomics 2005; 23 (7): 709–721PubMedCrossRef Lee KS, Brouwer WB, Lee SI, et al. Introducing economic evaluation as a policy tool in Korea: will decision makers get quality information? A critical review of published Korean economic evaluations. Pharmacoeconomics 2005; 23 (7): 709–721PubMedCrossRef
10.
Zurück zum Zitat O’Brien BJ. A tale of two (or more) cities: geographic transferability of pharmacoeconomic data. Am J Manag Care 1997; 3 Suppl.: S33–S39PubMed O’Brien BJ. A tale of two (or more) cities: geographic transferability of pharmacoeconomic data. Am J Manag Care 1997; 3 Suppl.: S33–S39PubMed
11.
Zurück zum Zitat Drummond M, Pang F. Transferability of economic evaluation results. In: Drummond M, McGuire A, editors. Economic evaluation in health care. Oxford: Oxford University Press, 2001: 256–276 Drummond M, Pang F. Transferability of economic evaluation results. In: Drummond M, McGuire A, editors. Economic evaluation in health care. Oxford: Oxford University Press, 2001: 256–276
12.
Zurück zum Zitat Teerawattananon Y, Mugford M. Is it worth offering a routine laparoscopic cholecystectomy in developing countries? A Thailand case study. Cost Eff Resour Alloc 2005; 3 (1): 10PubMedCrossRef Teerawattananon Y, Mugford M. Is it worth offering a routine laparoscopic cholecystectomy in developing countries? A Thailand case study. Cost Eff Resour Alloc 2005; 3 (1): 10PubMedCrossRef
13.
Zurück zum Zitat Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 1996; 313: 275–283PubMedCrossRef Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 1996; 313: 275–283PubMedCrossRef
14.
Zurück zum Zitat Drummond M, Sculpher M, Torrance G, et al. Method for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press, 2005 Drummond M, Sculpher M, Torrance G, et al. Method for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press, 2005
15.
Zurück zum Zitat Cooper N, Coyle D, Abrams K, et al. Use of evidence in decision models: an appraisal of health technology assessments in the UK since 1997. J Health Serv Res Policy 2005 Oct; 10 (4): 245–250PubMedCrossRef Cooper N, Coyle D, Abrams K, et al. Use of evidence in decision models: an appraisal of health technology assessments in the UK since 1997. J Health Serv Res Policy 2005 Oct; 10 (4): 245–250PubMedCrossRef
16.
Zurück zum Zitat Bundhamcharoen K, Teerawattananon Y, Theo V, et al. Burden of disease and injuries in Thailand: priority setting for policy. The Thai Working Group on Burden of Disease and Injuries. Bangkok: Printing House of the War Veterans Organization of Thailand, 2002 [online]. Available at URL: http://203.157.19.191/BURDEN.pdf [Accessed 14 Sep 2006] Bundhamcharoen K, Teerawattananon Y, Theo V, et al. Burden of disease and injuries in Thailand: priority setting for policy. The Thai Working Group on Burden of Disease and Injuries. Bangkok: Printing House of the War Veterans Organization of Thailand, 2002 [online]. Available at URL: http://​203.​157.​19.​191/​BURDEN.​pdf [Accessed 14 Sep 2006]
17.
Zurück zum Zitat Murray C, Lopez A. The global burden of diseases: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Boston: Harvard School of Public Health, WHO and World Bank, 1996 Murray C, Lopez A. The global burden of diseases: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Boston: Harvard School of Public Health, WHO and World Bank, 1996
18.
Zurück zum Zitat Neumann PJ, Rosen AB, Greenberg D, et al. Can we better prioritize resources for cost-utility research? Med Decis Making 2005; 25 (4): 429–436PubMedCrossRef Neumann PJ, Rosen AB, Greenberg D, et al. Can we better prioritize resources for cost-utility research? Med Decis Making 2005; 25 (4): 429–436PubMedCrossRef
19.
Zurück zum Zitat Oliver A. Health economic evaluation in Japan: a case study of one aspect of health technology assessment. Health Policy 2003; 63 (2): 197–204PubMedCrossRef Oliver A. Health economic evaluation in Japan: a case study of one aspect of health technology assessment. Health Policy 2003; 63 (2): 197–204PubMedCrossRef
20.
Zurück zum Zitat Neumann P. Using cost-effectiveness analysis to improve health care: opportunities and barriers. Oxford: Oxford University Press, 2005 Neumann P. Using cost-effectiveness analysis to improve health care: opportunities and barriers. Oxford: Oxford University Press, 2005
21.
Zurück zum Zitat Coast J. Is economic evaluation in touch with society’s health values? BMJ 2004; 329 (7476): 1233–6PubMedCrossRef Coast J. Is economic evaluation in touch with society’s health values? BMJ 2004; 329 (7476): 1233–6PubMedCrossRef
22.
Zurück zum Zitat Tan-Torres E, Baltussen R, Adum T, et al. Making CHOICES in health: WHO guide to cost-effectiveness analysis. Geneva: World Health Organization, 2003 Tan-Torres E, Baltussen R, Adum T, et al. Making CHOICES in health: WHO guide to cost-effectiveness analysis. Geneva: World Health Organization, 2003
23.
Zurück zum Zitat Drummond M, Sculpher M. Common methodological flaws in economic evaluations. Med Care 2005; 43 (7 Suppl.): 5–14PubMed Drummond M, Sculpher M. Common methodological flaws in economic evaluations. Med Care 2005; 43 (7 Suppl.): 5–14PubMed
24.
Zurück zum Zitat Wiwanitkit V. Comparison of cost effectiveness between measuring the serum erythropoietin level and reticulocyte count for monitoring thalassemic patients: a note in Thai beta thalassemia/HbE subjects. Hematology 2004; 9 (4): 311–3PubMedCrossRef Wiwanitkit V. Comparison of cost effectiveness between measuring the serum erythropoietin level and reticulocyte count for monitoring thalassemic patients: a note in Thai beta thalassemia/HbE subjects. Hematology 2004; 9 (4): 311–3PubMedCrossRef
25.
Zurück zum Zitat Cairns J. Discounting in economic evaluation. In: Drummond M, McGuire A, editors. Economic evaluation in health care: merging theory with practice. Oxford: Oxford University Press, 2001 Cairns J. Discounting in economic evaluation. In: Drummond M, McGuire A, editors. Economic evaluation in health care: merging theory with practice. Oxford: Oxford University Press, 2001
26.
Zurück zum Zitat World Health Organization. The world health report 2002: reducing risks, promoting healthy life. Geneva: World Health Organization, 2002 World Health Organization. The world health report 2002: reducing risks, promoting healthy life. Geneva: World Health Organization, 2002
Metadaten
Titel
A Systematic Review of Economic Evaluation Literature in Thailand
Are the Data Good Enough to be Used by Policy-Makers?
verfasst von
Dr Yot Teerawattananon
Steve Russell
Miranda Mugford
Publikationsdatum
01.06.2007
Verlag
Springer International Publishing
Erschienen in
PharmacoEconomics / Ausgabe 6/2007
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-200725060-00003

Weitere Artikel der Ausgabe 6/2007

PharmacoEconomics 6/2007 Zur Ausgabe